The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
A phase I study of veliparib (ABT-888) in combination with low-dose fractionated whole abdominal radiation therapy (LDFWAR) in patients with advanced solid malignancies and peritoneal carcinomatosis.
Kim Anna Reiss
No relevant relationships to disclose
Joseph M. Herman
No relevant relationships to disclose
Marianna Zahurak
No relevant relationships to disclose
Anthony M. Brade
No relevant relationships to disclose
Laura A. Dawson
No relevant relationships to disclose
Angela Scardina
No relevant relationships to disclose
Caitlin Joffe
No relevant relationships to disclose
Emily Petito
No relevant relationships to disclose
Amy Hacker-Prietz
No relevant relationships to disclose
Alice P. Chen
No relevant relationships to disclose
Sarah Madhu Temkin
No relevant relationships to disclose
Naomi Horiba
No relevant relationships to disclose
Lillian L. Siu
No relevant relationships to disclose
Nilofer Saba Azad
No relevant relationships to disclose